Torsten O. Nielsen
Journal of the National Cancer Institute · 2004–2020
A researcher in the Science corpus: 13 papers; trusts 0 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Whom Torsten O. Nielsen trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Torsten O. Nielsen overall
Papers from Torsten O. Nielsen's perspective
Ordered by how strongly the researchers Torsten O. Nielsen trusts endorse each paper. Same corpus, a different order for every researcher.
- Proliferation marker Ki-67 in early breast cancer. (Journal of Clinical Oncology)
- Validation of Tissue Microarray Technology in Breast Carcinoma (Laboratory Investigation)
- A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. (New England Journal of Medicine)
- The Ki‐67 protein: From the known and the unknown
- Aspirin for the Primary Prevention of Cardiovascular Events in Women and Men: A Sex-Specific Meta-Analysis of Randomized Controlled Trials (Journal of the American Medical Association (JAMA))
- A gene-expression signature as a predictor of survival in breast cancer. (New England Journal of Medicine)
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer (Archives of Pathology & Laboratory Medicine)
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications (Proceedings of the National Academy of Sciences of the United States of America)
- Molecular portraits of human breast tumours (Nature)
- Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group. (Journal of the National Cancer Institute)
Their papers
- Systematic Analysis of Breast Cancer Morphology Uncovers Stromal Features Associated with Survival (2011) — 747 citations
- deFuse: An Algorithm for Gene Fusion Discovery in Tumor RNA-Seq Data (2011) — 562 citations
- Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group. (2011) — 1,714 citations
- Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group (2020) — 663 citations
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. (2015) — 2,798 citations
- Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients. (2014) — 723 citations
- Metastatic behavior of breast cancer subtypes. (2010) — 2,071 citations
- Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies (2010) — 1,105 citations
- Supervised risk predictor of breast cancer based on intrinsic subtypes. (2009) — 4,443 citations
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer (2009) — 2,230 citations
- Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype (2008) — 1,210 citations
- Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma (2004) — 2,689 citations
- The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. (2004) — 656 citations